Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03586648 · ClinicalTrials.gov registry record · NA

Clinical Evaluation of a Reusable Multifocal Optical Design in a Presbyopic Population Phase 2

A NA study of Visual Acuity, sponsored by Johnson & Johnson Vision Care.

Completed
Registry status
NA
Development phase
71
Enrollment target
6
Study locations

NCT03586648 is a NA study of Visual Acuity that has completed, run by Johnson & Johnson Vision Care. The registered enrollment target is 71 participants, below the 137-participant average among 20 other Visual Acuity trials with a reported enrollment target (48% lower). The trial reports 6 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03586648, a NA study of Visual Acuity, has completed, sponsored by Johnson & Johnson Vision Care.

COMPLETED
Registry status
NA
Development phase
71 participants
Enrollment target
6
Study locations

Study Summary

This is a single-masked, randomized-controlled, dispensing clinical trial. A total of approximately 60 eligible hyperopic subjects will be targeted to complete this study.

Conditions Studied

Interventions

  • DEVICE senofilcon A Multifocal
  • DEVICE senofilcon A Sphere
  • DEVICE etafilcon A Multifocal
  • DEVICE etafilcon A Sphere

Study Locations (6)

Florida

  • Dr. James E. Weber - Jacksonville
  • Maitland Vision Center - Maitland
  • Wayne Golden, OD - Sarasota

Ohio

  • Western Reserve Vision Care - Beechwood
  • Procare Vision Center - Granville

California

  • Golden Optometric Group - Whittier

Trial Details

FieldValue
Enrollment Target 71 participants
Start Date 2018-06-14
Est. Completion 2018-08-20
Phase NA

Sponsor

Johnson & Johnson Vision Care

142 total trials

What the Registry Record Tells You About NCT03586648

The ClinicalTrials.gov registry entry for NCT03586648 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 71 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 137-participant average among 20 other Visual Acuity trials with a reported enrollment target (48% lower). The listed sponsor is Johnson & Johnson Vision Care, which has 142 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Visual Acuity appearing as the primary indexed condition, and to 4 interventions - of which senofilcon A Multifocal is the first listed.

NCT03586648 reports 6 study locations spanning 3 distinct geographic areas - top geographies include Florida, Ohio, California.

Frequently Asked Questions

What is clinical trial NCT03586648 about?

NCT03586648 is a clinical study titled "Clinical Evaluation of a Reusable Multifocal Optical Design in a Presbyopic Population Phase 2". This is a single-masked, randomized-controlled, dispensing clinical trial. A total of approximately 60 eligible hyperopic subjects will be targeted to complete this study.

What is the current status of trial NCT03586648?

This trial is currently completed. It is a NA study. The enrollment target is 71 participants. The study started on 2018-06-14. Estimated completion is 2018-08-20.

What conditions does trial NCT03586648 study?

This clinical trial studies the following conditions: Visual Acuity.

What interventions are being tested in trial NCT03586648?

The interventions under investigation include: senofilcon A Multifocal (DEVICE), senofilcon A Sphere (DEVICE), etafilcon A Multifocal (DEVICE), etafilcon A Sphere (DEVICE).

Who is sponsoring clinical trial NCT03586648?

This trial is sponsored by Johnson & Johnson Vision Care, which has 142 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03586648 being conducted?

This trial has 6 study locations across California, Florida, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Visual Acuity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.